Livzon Pharmaceutical Group Inc. Livzon Pharmaceutical Group Inc.

Livzon Pharmaceutical Group Inc.

000513

주식 순위 #4689
Livzon Pharmaceutical Group Inc., headquartered in Zhuhai, China, and... Livzon Pharmaceutical Group Inc., headquartered in Zhuhai, China, and established in 1985, is a biopharmaceutical enterprise operating across the entire spectrum of pharmaceutical activities, from research and development to manufacturing and commercialization. The company's operations encompass a diverse range of finished drug products, active pharmaceutical ingredients (APIs), and chemical intermediates, primarily serving the Chinese market while also engaging in international exports. Its pharmaceutical portfolio includes treatments such as Ilaprazole enteric coated tablets for duodenal ulcers and reflux esophagitis, Laprazole sodium injection for managing peptic ulcer bleeding, Leuprorelin Acetate Microspheres for injection, and Urofollitropin injection for anovulation and fertility support. Livzon also produces Perospirone Hydrochloride for schizophrenia, Anti-viral Granules targeting upper respiratory tract infections and influenza, and Shenqi Fuzheng Injection, which addresses general weakness, fatigue, spontaneous sweating, and vertigo, and provides supportive care for lung and stomach cancer patients. Beyond therapeutic drugs, Livzon Pharmaceutical Group develops and distributes a variety of diagnostic reagents. These include kits for detecting IgM/IgG antibodies to coronavirus, nucleic acid tests for human immunodeficiency virus type 1, antinuclear antibody test kits, interferon-gamma release assay kits, and rapid tests for mycoplasma pneumoniae IgM antibodies. The company's extensive offerings further extend to biochemical drugs, microbiological preparations, biologics, traditional Chinese medicine formulations, pharmaceutical raw materials, and antibiotics.
주가
$3.90
시가총액
$3.17B
변동 (1일)
-3.49%
변동 (1년)
-25.88%
국가
CN
거래 Livzon Pharmaceutical Group Inc. (000513)

카테고리

Healthcare
Livzon Pharmaceutical Group Inc. (000513)의 주식 분할 이력
Livzon Pharmaceutical Group Inc. 주식 (심볼: 000513)은 총 7회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Jul 03, 2019에 발생했습니다.
May 26, 1994 이전에 매수한 000513 주식 1주는 현재 5.07664834677주의 000513 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
2019-07-03 13:10 x1.3 x5.07664834677
2018-06-22 13:10 x1.3 x3.9051141129
2017-07-07 13:10 x1.3 x3.003933933
2015-08-14 13:10 x1.3 x2.31071841
2006-12-11 11:10 x1.1 x1.7774757
1997-09-04 124299:100000 x1.24299 x1.615887
1994-05-26 13:10 x1.3 x1.3
유사 기업 또는 경쟁사의 주식 분할